Lv11
100 积分 2023-03-16 加入
Efficacy and safety of QY201, an oral dual Janus kinase 1/tyrosine kinase 2 inhibitor, in adults with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 2 dose-finding trial
4小时前
待确认
Efficacy and safety of filgotinib in patients with active radiographic and nonradiographic axial spondyloarthritis: results from OLINGUITO, a phase 3 trial consisting of 2 randomised, placebo-controlled, double-blind, parallel-group studies
1个月前
已完结
52‐week ivarmacitinib in moderate‐to‐severe atopic dermatitis: A phase 3 trial
1个月前
已完结
Safety and efficacy of the selective tyrosine kinase 2/Janus kinase 1 inhibitor TLL-018 in patients with moderate-to-severe chronic spontaneous urticaria with inadequate response to H1 antihistamines: a phase Ib, randomized, double-blind, placebo-controlled pilot study
1个月前
已完结
Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial
2个月前
已完结
Safety, tolerability, and pharmacokinetics of HL-300, a novel topical pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial
3个月前
已完结
Randomized dose-finding study of anti-KIT barzolvolimab in patients with chronic spontaneous urticaria
4个月前
已完结
Osteoarthritis: Joint Anatomy, Physiology, and Pathobiology
5个月前
已完结
Organ-specific tumor dynamics predict survival of patients with metastatic colorectal cancer
5个月前
已完结
Long‐term efficacy of abrocitinib in patients with moderate‐to‐severe atopic dermatitis to 2 years
5个月前
已完结
皖公网安备34019202002308
